To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Apollo goes to court over Huntsman
The buyout firm and portfolio company Hexion have begun court proceedings in an attempt to abandon the $10.6bn purchase of chemical manufacturer Huntsman citing a material adverse effect. Yesterday, an offer of nearly $1bn from investors in order to close the transaction was declined by Hexion.
